Contact
searchSearch
HMP Global

Allergy & Immunology

Features

Research Highlights
Early Egg Introduction Linked to Lower Infant Egg Allergy
07/20/2026
Rebecca Mashaw
The investigators concluded that their findings provide population-level evidence that earlier egg introduction, as recommended by updated infant feeding guidelines, was associated with reduced egg allergy prevalence when implemented in...
The investigators concluded that their findings provide population-level evidence that earlier egg introduction, as recommended by updated infant feeding guidelines, was associated with reduced egg allergy prevalence when implemented in...
The investigators concluded that...
07/20/2026
Allergy & Immunology
Research Review
Study Links Chronic Spontaneous Urticaria to Increased Mortality Risk
07/01/2026
Jessica Garlewicz
Age, race, and treatment status factored into higher rates of all-cause mortality and serious comorbidities among patients with chronic spontaneous urticaria, investigators found.
Age, race, and treatment status factored into higher rates of all-cause mortality and serious comorbidities among patients with chronic spontaneous urticaria, investigators found.
Age, race, and treatment status...
07/01/2026
Allergy & Immunology
Research Highlights
Omalizumab Reduced Anaphylaxis Burden in Patients With Idiopathic MCAS
06/22/2026
Jessica Garlewicz
Treatment approaches remain variable for idiopathic mast cell activation syndrome because of its rarity and clinical heterogeneity.
Treatment approaches remain variable for idiopathic mast cell activation syndrome because of its rarity and clinical heterogeneity.
Treatment approaches remain...
06/22/2026
Allergy & Immunology
Guidance
New Yardstick Outlines Treatment Approach for MCAS and Indolent Systemic Mastocytosis
06/22/2026
Jessica Garlewicz
Because MCAS and ISM can present with broad, overlapping symptoms, the authors emphasize diagnostic confirmation before initiating a treatment plan.
Because MCAS and ISM can present with broad, overlapping symptoms, the authors emphasize diagnostic confirmation before initiating a treatment plan.
Because MCAS and ISM can present...
06/22/2026
Allergy & Immunology
Research Summary
Case Series Suggests Potential Role for GLP-1 Receptor Agonists in MCAS
06/22/2026
Jessica Garlewicz
The report did not identify a single dominant symptom domain but instead described improvement across multiple manifestations of the syndrome.
The report did not identify a single dominant symptom domain but instead described improvement across multiple manifestations of the syndrome.
The report did not identify a...
06/22/2026
Allergy & Immunology
Gut Check logo
Expert Insights
Gut Check: Jacqueline Squire, MD, on the Gastric Impacts of MCAS
06/19/2026
Brian E. Lacy, PhD, MD; Jacqueline Squire, MD
Drs Jacqueline Squire and Brian Lacy review the challenges of accurately diagnosing mast cell activation syndrome, how it affects the gastrointestinal and other organ systems, and how best to treatment this relatively rare and often...
Drs Jacqueline Squire and Brian Lacy review the challenges of accurately diagnosing mast cell activation syndrome, how it affects the gastrointestinal and other organ systems, and how best to treatment this relatively rare and often...
Drs Jacqueline Squire and Brian...
06/19/2026
Gastroenterology
From Gastroenterology
Research Review
Mast Cell Activation Syndrome Review Highlights Diagnostic Gaps and Research Needs
06/19/2026
Rebecca Mashaw
A recent review underscores substantial uncertainties remain regarding the definition, diagnosis, and underlying biology of MCAS, calling for standardized criteria, better biomarkers, and high-quality prospective research improve diagnostic...
A recent review underscores substantial uncertainties remain regarding the definition, diagnosis, and underlying biology of MCAS, calling for standardized criteria, better biomarkers, and high-quality prospective research improve diagnostic...
A recent review underscores...
06/19/2026
Allergy & Immunology
Guidance
Diagnosis and Management of Mast Cell Activation Disorders: New Clinical Guidance
06/18/2026
Rebecca Mashaw
An expert review highlights the expanding clinical burden of mast cell activation disorders and the need for consistent diagnostic and management strategies.
An expert review highlights the expanding clinical burden of mast cell activation disorders and the need for consistent diagnostic and management strategies.
An expert review highlights the...
06/18/2026
Allergy & Immunology
Research Insights
Global Consensus-2 Criteria Expand Recognition of Mast Cell Activation Syndrome
06/18/2026
Rebecca Mashaw
Six years after introduction of the Consensus-2 diagnostic criteria for mast cell activation syndrome, a new review argues that broader diagnostic recognition has improved identification of patients with mast-cell–mediated disease.
Six years after introduction of the Consensus-2 diagnostic criteria for mast cell activation syndrome, a new review argues that broader diagnostic recognition has improved identification of patients with mast-cell–mediated disease.
Six years after introduction of...
06/18/2026
Allergy & Immunology
Research Review
Maternal Asthma Control During Pregnancy Linked to Pre-Eclampsia Risk
06/15/2026
Rebecca Mashaw
A recent systematic review suggests that uncontrolled asthma and exacerbations during pregnancy may elevate the risk of pre-eclampsia.
A recent systematic review suggests that uncontrolled asthma and exacerbations during pregnancy may elevate the risk of pre-eclampsia.
A recent systematic review...
06/15/2026
Allergy & Immunology
Michael Wechsler
Expert Insights
Michael Wechsler, MD, on Updates to GINA Guidelines for Asthma
06/14/2026
Michael E. Wechsler, MD
Dr Wechsler reviews key updates to the Global Initiative for Asthma (GINA) 2026, including the addition of combination therapies and new biologics, new assessment methods, inhaler techniques, and more.
Dr Wechsler reviews key updates to the Global Initiative for Asthma (GINA) 2026, including the addition of combination therapies and new biologics, new assessment methods, inhaler techniques, and more.
Dr Wechsler reviews key updates...
06/14/2026
Allergy & Immunology

Videos

Michael Wechsler
Expert Insights
Michael Wechsler, MD, on Updates to GINA Guidelines for Asthma
06/14/2026
Michael E. Wechsler, MD
Dr Wechsler reviews key updates to the Global Initiative for Asthma (GINA) 2026, including the addition of combination therapies and new biologics, new assessment methods, inhaler techniques, and more.
Dr Wechsler reviews key updates to the Global Initiative for Asthma (GINA) 2026, including the addition of combination therapies and new biologics, new assessment methods, inhaler techniques, and more.
Dr Wechsler reviews key updates...
06/14/2026
Allergy & Immunology
Conference Coverage
Kathryn Peterson, MD, on Diagnosing and Treating Eosinophilic Gastritis
03/25/2026
Kathryn Peterson, MD, MS
Dr Kathryn Peterson provides an overview of her presentation at the American Academy of Allergy, Asthma, and Immunology on eosinophilic gastric diseases other than EoE, including the challenges of diagnosis and options for treatment.
Dr Kathryn Peterson provides an overview of her presentation at the American Academy of Allergy, Asthma, and Immunology on eosinophilic gastric diseases other than EoE, including the challenges of diagnosis and options for treatment.
Dr Kathryn Peterson provides an...
03/25/2026
Allergy & Immunology
Peter Lio
Clinical Insights
Chemical Exposures, Pollen Flares & the Microbiome in Atopic Dermatitis
03/16/2026
Peter Lio, MD, FAAD
Learn how household chemicals, airborne pollutants, and seasonal pollen surges drive atopic dermatitis flares. Dr Peter Lio examines environmental triggers and microbiome disruption in AD for allergists and immunologists.
Learn how household chemicals, airborne pollutants, and seasonal pollen surges drive atopic dermatitis flares. Dr Peter Lio examines environmental triggers and microbiome disruption in AD for allergists and immunologists.
Learn how household chemicals,...
03/16/2026
Allergy & Immunology
RESEARCH INSIGHTS
Thomas Casale, MD, on the Efficacy of Dupilumab for Chronic Spontaneous Urticaria
03/13/2026
Thomas B. Casale, MD
Dr Casale provides an overview of his poster presentation at the American Academy of Allergy, Asthma, and Immunology annual meeting on whether age, gender, BMI, presence of angioedema, or IgE level affected how patients with chronic...
Dr Casale provides an overview of his poster presentation at the American Academy of Allergy, Asthma, and Immunology annual meeting on whether age, gender, BMI, presence of angioedema, or IgE level affected how patients with chronic...
Dr Casale provides an overview...
03/13/2026
Allergy & Immunology
Peter Lio
Expert Insights
Environmental Triggers of Atopic Dermatitis & Seasonal Allergies
03/05/2026
Peter Lio, MD, FAAD; Riya Gandhi, MA
In this interview, Peter Lio, MD, explores how modern environmental exposures—from pollution to lifestyle shifts—are accelerating type 2 inflammation and fueling atopic dermatitis and seasonal allergies in today’s patients.
In this interview, Peter Lio, MD, explores how modern environmental exposures—from pollution to lifestyle shifts—are accelerating type 2 inflammation and fueling atopic dermatitis and seasonal allergies in today’s patients.
In this interview, Peter Lio,...
03/05/2026
Allergy & Immunology
Allen Kaplan
RESEARCH INSIGHTS
Diagnostic Challenges and Clinical Pitfalls in HAE
03/02/2026
Allen P. Kaplan, MD
Dr Allen Kaplan reviews common diagnostic pitfalls in hereditary angioedema, including misinterpretation of complement testing, confusion with histaminergic angioedema, and challenges in identifying HAE with normal C1 inhibitor.
Dr Allen Kaplan reviews common diagnostic pitfalls in hereditary angioedema, including misinterpretation of complement testing, confusion with histaminergic angioedema, and challenges in identifying HAE with normal C1 inhibitor.
Dr Allen Kaplan reviews common...
03/02/2026
Allergy & Immunology
Allen Kaplan
CLINICAL INSIGHTS
Differentiating Hereditary Angioedema From Its Mimics
02/09/2026
Allen P. Kaplan, MD
Allen Kaplan, MD, discusses how to distinguish hereditary angioedema from common angioedema mimics, including histaminergic and ACE inhibitor–associated angioedema.
Allen Kaplan, MD, discusses how to distinguish hereditary angioedema from common angioedema mimics, including histaminergic and ACE inhibitor–associated angioedema.
Allen Kaplan, MD, discusses how...
02/09/2026
Allergy & Immunology
Joy Chang
Expert Insights
Joy Chang, MD, on Step Therapy for EoE: Part 2
02/05/2026
Joy Chang, MD
Dr Joy Chang continues her tutorial on therapy for eosinophilic esophagitis, including options for using dupilimab as step-down therapy for specific patients.
Dr Joy Chang continues her tutorial on therapy for eosinophilic esophagitis, including options for using dupilimab as step-down therapy for specific patients.
Dr Joy Chang continues her...
02/05/2026
Allergy & Immunology
Joy Chang
Conference Insights
Joy Chang, MD, on Step Therapy for EoE: Part 1
01/26/2026
Joy Chang, MD
In this video, Dr Joy Chang begins a two-part discussion on using step-up and step-down therapy in the treatment of eosinophilic esophagitis based on her presentation at the ACG scientific meeting.
In this video, Dr Joy Chang begins a two-part discussion on using step-up and step-down therapy in the treatment of eosinophilic esophagitis based on her presentation at the ACG scientific meeting.
In this video, Dr Joy Chang...
01/26/2026
Allergy & Immunology
Peter Lio
Clinical Insights
Urbanization, Lifestyle, and Skin Barrier Damage in Atopic Dermatitis
01/20/2026
Peter Lio, MD, FAAD; Riya Gandhi, MA
Dr Peter Lio discusses how urbanization, modern lifestyles, and shifting environmental exposures may be driving rising rates of allergic rhinitis, food allergy, and atopic dermatitis—and which exposures should most concern clinicians.
Dr Peter Lio discusses how urbanization, modern lifestyles, and shifting environmental exposures may be driving rising rates of allergic rhinitis, food allergy, and atopic dermatitis—and which exposures should most concern clinicians.
Dr Peter Lio discusses how...
01/20/2026
Allergy & Immunology

Interactive Features

Interactive Features
Diagnostic Approach for Pediatric AD with Food Allergies
04/24/2026
Riya Gandhi, MA
Test your knowledge on effective diagnostic strategies for identifying overlapping atopic dermatitis and food allergies in pediatric patients, including clinical history and functional testing tools.
Test your knowledge on effective diagnostic strategies for identifying overlapping atopic dermatitis and food allergies in pediatric patients, including clinical history and functional testing tools.
Test your knowledge on effective...
04/24/2026
Allergy & Immunology
Quiz
Shared Pathophysiology of AD and Food Allergies in Children
04/22/2026
Riya Gandhi, MA
Test your understanding of the overlapping immune and barrier mechanisms that link atopic dermatitis and food allergies in pediatric patients, including insights from recent pathophysiologic research.
Test your understanding of the overlapping immune and barrier mechanisms that link atopic dermatitis and food allergies in pediatric patients, including insights from recent pathophysiologic research.
Test your understanding of the...
04/22/2026
Allergy & Immunology
Quiz
Coordinated Management Strategies for Pediatric AD and Food Allergies
04/20/2026
Riya Gandhi, MA
This quiz evaluates your ability to apply a coordinated, multidisciplinary approach to managing children with both atopic dermatitis and food allergies, with an emphasis on prevention and personalization.
This quiz evaluates your ability to apply a coordinated, multidisciplinary approach to managing children with both atopic dermatitis and food allergies, with an emphasis on prevention and personalization.
This quiz evaluates your ability...
04/20/2026
Allergy & Immunology
Quiz
Regional Barriers to EoE Treatment
04/19/2026
Riya Gandhi, MA
Learn about regional disparities in eosinophilic esophagitis treatment, including limited access to advanced therapies and noninvasive monitoring tools in underserved communities.
Learn about regional disparities in eosinophilic esophagitis treatment, including limited access to advanced therapies and noninvasive monitoring tools in underserved communities.
Learn about regional disparities...
04/19/2026
Allergy & Immunology
Quiz
How Prophylactic Therapies Are Shaping the Future of HAE Care
03/15/2026
Riya Gandhi, MA
Explore the clinical impact of contemporary prophylactic therapies in hereditary angioedema, including their effect on attack frequency, patient quality of life, and treatment strategies.
Explore the clinical impact of contemporary prophylactic therapies in hereditary angioedema, including their effect on attack frequency, patient quality of life, and treatment strategies.
Explore the clinical impact of...
03/15/2026
Allergy & Immunology
Quiz
Skin Barrier Abnormalities and Immune Triggers in Pediatric AD
03/05/2026
Riya Gandhi, MA
Explore how structural changes in the skin contribute to systemic immune activation in children with atopic dermatitis. This quiz highlights key pathophysiologic drivers relevant to clinical care.
Explore how structural changes in the skin contribute to systemic immune activation in children with atopic dermatitis. This quiz highlights key pathophysiologic drivers relevant to clinical care.
Explore how structural changes...
03/05/2026
Allergy & Immunology
Quiz
Future Therapies in HAE: What’s Driving Innovation?
03/01/2026
Riya Gandhi, MA
Dive into next-generation treatment strategies in hereditary angioedema in reshaping long-term care.
Dive into next-generation treatment strategies in hereditary angioedema in reshaping long-term care.
Dive into next-generation...
03/01/2026
Allergy & Immunology
Quiz
Therapeutic Goals in Children with AD and Food Allergies
02/27/2026
Riya Gandhi, MA
Assess your understanding of treatment priorities in pediatric patients with concurrent atopic dermatitis and food allergies, focusing on integrated care strategies for long-term management.
Assess your understanding of treatment priorities in pediatric patients with concurrent atopic dermatitis and food allergies, focusing on integrated care strategies for long-term management.
Assess your understanding of...
02/27/2026
Allergy & Immunology
Quiz
Therapeutic Innovations in HAE
01/11/2026
Do you know about the most recent advances in therapies for hereditary angioedema? Take our quiz to test your knowledge!
Do you know about the most recent advances in therapies for hereditary angioedema? Take our quiz to test your knowledge!
Do you know about the most...
01/11/2026
Allergy & Immunology
Quiz
Incidence Stability in Chronic Urticaria
01/05/2026
Riya Gandhi, MA
Assess longitudinal trends in chronic urticaria incidence across a five-year period, including during the pandemic and vaccination phases, in this data-driven quiz.
Assess longitudinal trends in chronic urticaria incidence across a five-year period, including during the pandemic and vaccination phases, in this data-driven quiz.
Assess longitudinal trends in...
01/05/2026
Allergy & Immunology

Conference Coverage

Feser
Conference Coverage
Emerging Therapies Target Mast Cell Pathways in Chronic Spontaneous Urticaria
05/15/2026
Jessica Garlewicz
Chronic spontaneous urticaria remains a persistent and often refractory condition, with more than half of patients continuing to experience symptoms despite standard antihistamine therapy.
Chronic spontaneous urticaria remains a persistent and often refractory condition, with more than half of patients continuing to experience symptoms despite standard antihistamine therapy.
Chronic spontaneous urticaria...
05/15/2026
The Dermatologist
Research Review
Many Eliminated Foods Tolerated in Children With Atopic Dermatitis
04/01/2026
Riya Gandhi, MA
IgE testing may result in unneeded food elimination diets among children with atopic dermatitis, investigators reported.
IgE testing may result in unneeded food elimination diets among children with atopic dermatitis, investigators reported.
IgE testing may result in...
04/01/2026
Allergy & Immunology
Research Highlights
Sublingual Immunotherapy Outperforms Subcutaneous Allergoids in 2-Year Asthma Trial
04/01/2026
Riya Gandhi, MA
Sublingual immunotherapy achieved better asthma control and inflammatory biomarker reduction when compared to subcutaneous allergoid immunotherapy.
Sublingual immunotherapy achieved better asthma control and inflammatory biomarker reduction when compared to subcutaneous allergoid immunotherapy.
Sublingual immunotherapy...
04/01/2026
Allergy & Immunology
Conference Coverage
Nearly Half of Children With Primary Immunodeficiencies Carry Drug Allergy Labels
04/01/2026
Riya Gandhi, MA
Drug allergy evaluations are needed to prevent limitations of treatment options for children with primary immunodeficiencies, researchers stated at the AAAAI annual meeting.
Drug allergy evaluations are needed to prevent limitations of treatment options for children with primary immunodeficiencies, researchers stated at the AAAAI annual meeting.
Drug allergy evaluations are...
04/01/2026
Allergy & Immunology
Conference Coverage
Barriers Limit Allergy and Immunology Referrals in Pregnancy
11/14/2025
Rebecca Mashaw
A significant majority of obstetricians surveyed were interested in receiving additional education and guidelines to help them guide care of pregnant patients with allergies.
A significant majority of obstetricians surveyed were interested in receiving additional education and guidelines to help them guide care of pregnant patients with allergies.
A significant majority of...
11/14/2025
Allergy & Immunology
Conference Coverage
Plasma-Guided Adaptive Chemoimmunotherapy for Patients With First-Line Non-Small Cell Lung Cancer
05/27/2025
Allison Casey
According to a prospective clinical trial, the use of plasma-guided adaptive treatment led to a median progression-free survival comparable to historical controls for patients with advanced PD-L1–positive non-small cell lung cancer.
According to a prospective clinical trial, the use of plasma-guided adaptive treatment led to a median progression-free survival comparable to historical controls for patients with advanced PD-L1–positive non-small cell lung cancer.
According to a prospective...
05/27/2025
Oncology
Conference Coverage
Beyond PPIs: Evan S. Dellon, MD, on Approaches Treating to EoE
12/22/2023
Evan S. Dellon, MD
Treatment of eosinophilic esophagitis can go beyond the use of proton pump inhibitors alone, Evan Dellon, MD, stated during his presentation at the ACG Postgraduate Course.
Treatment of eosinophilic esophagitis can go beyond the use of proton pump inhibitors alone, Evan Dellon, MD, stated during his presentation at the ACG Postgraduate Course.
Treatment of eosinophilic...
12/22/2023
Gastroenterology
Insights from ACAAI 2022
Common Food Allergies
11/30/2022
Theresa A. Bingemann, MD
In this video, Theresa Bingemann, MD, reviews recent literature about early-introduction foods to prevent food allergy, some of the most common food allergies, and outgrowing food allergies. Dr Bingemann also spoke about these topics during...
In this video, Theresa Bingemann, MD, reviews recent literature about early-introduction foods to prevent food allergy, some of the most common food allergies, and outgrowing food allergies. Dr Bingemann also spoke about these topics during...
In this video, Theresa...
11/30/2022
Allergy & Immunology

In the News

Research Highlights
BTK Inhibition With Rilzabrutinib Improves Symptoms in Uncontrolled Asthma
05/06/2026
Jessica Garlewicz
Researchers found Bruton's tyrosine kinase inhibition was associated with a numerical decrease in loss of asthma control and may represent “a novel mechanism to treat uncontrolled symptomatic asthma.”
Researchers found Bruton's tyrosine kinase inhibition was associated with a numerical decrease in loss of asthma control and may represent “a novel mechanism to treat uncontrolled symptomatic asthma.”
Researchers found Bruton's...
05/06/2026
Allergy & Immunology
Research Review
Remibrutinib Shows Promise in IgE-Mediated Peanut Allergy
04/23/2026
Riya Gandhi, MA
These findings support continued development of remibrutinib as a potential oral therapeutic option for food allergy.
These findings support continued development of remibrutinib as a potential oral therapeutic option for food allergy.
These findings support continued...
04/23/2026
Allergy & Immunology
Research Review
Higher Phytochemical Intake Linked to Improved Pediatric Asthma Outcomes
03/18/2026
Rebecca Mashaw
Among the 150 children with asthma, those with higher Dietary Phytochemical Index intake had significantly better clinical scores and lower levels of inflammation than those in the lowest tertile.
Among the 150 children with asthma, those with higher Dietary Phytochemical Index intake had significantly better clinical scores and lower levels of inflammation than those in the lowest tertile.
Among the 150 children with...
03/18/2026
Allergy & Immunology
Research Summary
Acute Urticaria Incidence Declined During COVID-19
03/18/2026
Jessica Garlewicz
The findings of an analysis underscore the potential role of common viral infections as a trigger for AU and offer insight into changing disease patterns during the COVID-19 pandemic.
The findings of an analysis underscore the potential role of common viral infections as a trigger for AU and offer insight into changing disease patterns during the COVID-19 pandemic.
The findings of an analysis...
03/18/2026
Allergy & Immunology
Emerging Therapies
Advances in HAE Therapeutics Highlight Path Toward Personalized, Patient-Centered Care
03/02/2026
Jessica Garlewicz
The future of HAE management will likely focus on tailoring regimens to patient-specific needs, attack phenotypes, and treatment goals.
The future of HAE management will likely focus on tailoring regimens to patient-specific needs, attack phenotypes, and treatment goals.
The future of HAE management...
03/02/2026
Allergy & Immunology
FDA Alert
FDA Approves Twice-Yearly Biologic for Severe Eosinophilic Asthma
02/18/2026
Jessica Garlewicz
Exdensur is the first ultra-long-acting biologic for this population, with a dosing schedule of just twice per year.
Exdensur is the first ultra-long-acting biologic for this population, with a dosing schedule of just twice per year.
Exdensur is the first...
02/18/2026
Allergy & Immunology
Research Review
MDD in Asthma Patients Associated With Worse Outcomes in Older Adults
01/29/2026
Rebecca Mashaw
A recent cohort study by highlights how psychological health influences asthma control and healthcare utilization, underscoring a need for integrated care in older populations.
A recent cohort study by highlights how psychological health influences asthma control and healthcare utilization, underscoring a need for integrated care in older populations.
A recent cohort study by...
01/29/2026
Allergy & Immunology
Research Summary
Barriers to Normalization Persist for U.S. Patients With Hereditary Angioedema
01/18/2026
Rebecca Mashaw
New survey data highlight persistent disease burden, frequent attacks, and widespread concern about lifelong medication use among patients being treated for hereditary angioedema.
New survey data highlight persistent disease burden, frequent attacks, and widespread concern about lifelong medication use among patients being treated for hereditary angioedema.
New survey data highlight...
01/18/2026
Allergy & Immunology
Comorbidities
Oscillometry-Based Markers Reveal Airway Dynamics in Asthma–OSA Overlap
12/06/2025
Jessica Garlewicz
While the exact mechanistic interactions remain complex, oscillometric patterns provided insight into changes in respiratory rhythm and resistance related to nocturnal airway collapse and remodeling.
While the exact mechanistic interactions remain complex, oscillometric patterns provided insight into changes in respiratory rhythm and resistance related to nocturnal airway collapse and remodeling.
While the exact mechanistic...
12/06/2025
Allergy & Immunology
Morbidity & Mortality
Mortality From Coexisting Asthma and Cardiovascular Disease Rising
12/06/2025
Jessica Garlewicz
This analysis found significant disparities in mortality across demographic groups.
This analysis found significant disparities in mortality across demographic groups.
This analysis found significant...
12/06/2025
Allergy & Immunology

Popular Articles

Emerging Therapies
Advances in HAE Therapeutics Highlight Path Toward Personalized, Patient-Centered Care
03/02/2026
Jessica Garlewicz
The future of HAE management will likely focus on tailoring regimens to patient-specific needs, attack phenotypes, and treatment goals.
The future of HAE management will likely focus on tailoring regimens to patient-specific needs, attack phenotypes, and treatment goals.
The future of HAE management...
03/02/2026
Allergy & Immunology
Research Highlights
Cough-Variant Asthma Underdiagnosed Worldwide
02/05/2026
Rebecca Mashaw
A recent review underscores that CVA often coexists with conditions such as gastroesophageal reflux and chronic rhinitis, complicating clinical recognition.
A recent review underscores that CVA often coexists with conditions such as gastroesophageal reflux and chronic rhinitis, complicating clinical recognition.
A recent review underscores that...
02/05/2026
Allergy & Immunology
Research Review
Study Links Chronic Spontaneous Urticaria to Increased Mortality Risk
07/01/2026
Jessica Garlewicz
Age, race, and treatment status factored into higher rates of all-cause mortality and serious comorbidities among patients with chronic spontaneous urticaria, investigators found.
Age, race, and treatment status factored into higher rates of all-cause mortality and serious comorbidities among patients with chronic spontaneous urticaria, investigators found.
Age, race, and treatment status...
07/01/2026
Allergy & Immunology
News
Immune Checkpoint Inhibitor Regimens Drive Higher Costs in First-Line NSCLC Treatment
05/13/2025
Lisa Kuhns, PhD, MD
First-line (1L) treatment with immune checkpoint inhibitors (ICIs), particularly in combination with chemotherapy, is the most frequently used and costliest systemic therapy for metastatic non-small cell lung cancer (NSCLC) patients without...
First-line (1L) treatment with immune checkpoint inhibitors (ICIs), particularly in combination with chemotherapy, is the most frequently used and costliest systemic therapy for metastatic non-small cell lung cancer (NSCLC) patients without...
First-line (1L) treatment with...
05/13/2025
First Report Managed Care
Joy Chang
Conference Insights
Joy Chang, MD, on Step Therapy for EoE: Part 1
01/26/2026
Joy Chang, MD
In this video, Dr Joy Chang begins a two-part discussion on using step-up and step-down therapy in the treatment of eosinophilic esophagitis based on her presentation at the ACG scientific meeting.
In this video, Dr Joy Chang begins a two-part discussion on using step-up and step-down therapy in the treatment of eosinophilic esophagitis based on her presentation at the ACG scientific meeting.
In this video, Dr Joy Chang...
01/26/2026
Allergy & Immunology

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use